메디아나
9,230KRWMarket close of 10/20 (Tue)
Down -2.33%-220KRWMarket close of 10/20 (Tue)
- Open
- 9,320
- High
- 9,640
- Low
- 9,050
- Day range
- Day range low 9,050 high 9,640, open 9,320, close 9,230, previous close 9,450
- Volume
- 5×10K shares
- 436.51 million KRW 0.69× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
18%1-year close range 4,870 to 28,650 won, 18% up from the low
18% of the way up from the lowest close in 1 year (252 sessions) · -67.8% from the high
Usual range
Nothing unusual in the 4 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
- Daily moveusual range-2.33%-2.33%, 0.9× the usual (20-session average ±2.73%)That day -2.33% · usual ±2.73% · large-move threshold ±5.5%
The other 3 are within the usual range
- Trading value0.7×usual range
- EarningsOperating income, 8 quarters
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue16.1B KRW
- vs. year ago
- +7.0%
- vs. prior quarter
- -16.4%
- Operating income1.6B KRW
- vs. year ago
- +28.1%
- vs. prior quarter
- -14.1%
- Operating margin10.0%
- vs. year ago
- +1.6 pp
- vs. prior quarter
- +0.3 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 의료·정밀기기
Down -4.35%· 14 of 100 stocks up, preferred shares excluded · trading value 277.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 빅텍 | Close over the last 20 sessions +15.7% | Up +10.98% | 76.6B KRW |
| 큐리옥스바이오시스템즈 | Close over the last 20 sessions +14.0% | Down -22.08% | 56.8B KRW |
| 케이씨텍 | Close over the last 20 sessions +29.1% | Down -9.36% | 22.5B KRW |
| 티에스이 | Close over the last 20 sessions +8.2% | Down -6.07% | 22.5B KRW |
| 디아이 | Close over the last 20 sessions +13.1% | Down -8.39% | 21.3B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.